enVVeno Medical (NVNO) Retained Earnings (2017 - 2026)

enVVeno Medical's Retained Earnings history runs 10 years deep, the most recent figure standing at -$175.2 million for Q1 2026.

• On a quarterly basis, Retained Earnings fell 189.99% year-over-year to -$175.2 million in Q1 2026; TTM through Mar 2026 was -$175.2 million, a 189.99% decrease from a year earlier, with the FY2025 full-year figure at $198.5 million, up 2.29% from the prior year.
• Retained Earnings declined to -$175.2 million in Q1 2026 per NVNO's latest filing, from $198.5 million in the prior quarter.
• Across five years, Retained Earnings topped out at $198.5 million in Q4 2025 and bottomed at -$175.2 million in Q1 2026.
• The 5-year median for Retained Earnings is -$100.3 million (2022), against an average of -$4.9 million.
• Across the five-year window, Retained Earnings jumped 299.79% in 2022 and slumped 189.99% in 2026, its largest moves.
• Year by year, Retained Earnings stood at $145.2 million in 2022, then increased by 21.33% to $176.2 million in 2023, then increased by 10.09% to $194.0 million in 2024, then climbed by 2.29% to $198.5 million in 2025, then plunged by 188.27% to -$175.2 million in 2026.
• Per Business Quant, the three latest NVNO Retained Earnings figures stand at -$175.2 million (Q1 2026), $198.5 million (Q4 2025), and -$167.6 million (Q3 2025).